Results 261 to 270 of about 186,531 (283)

Early beta-blocker exposure and association with brain injury biomarkers following moderate to severe traumatic brain injury: A TRACK-TBI study. [PDF]

J Intensive Care Soc
Wongsripuemtet P, Ohnuma T, Temkin N, Barber J, Komisarow J, Manley GT, Hatfield J, Treggiari M, Colton K, Sasannejad C, Chaikittisilpa N, Grandhi R, Laskowitz DT, Mathew JP, Hernandez A, James ML, Raghunathan K, Miller JB, Vavilala MS, Goldstein B, Krishnamoorthy V, TRACK-TBI Investigators.   +21 more
europepmc   +1 more source

Health at Older Ages: The Causes and Consequences of Declining Disability among the Elderly [PDF]

David M. Cutler, Kate A. Stewart, Mary Beth Landrum   +2 more
core  

Health Care Issues in the United States and Japan [PDF]

Akihiko Iguchi, Haruko Noguchi, Jeffery Geppert, Mark McClellan, Masafumi Kuzuya, Yuichiro Masuda   +5 more
core  

Some of the next articles are maybe not open access.

Related searches:

Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction.

JACC. Heart failure, 2023
BACKGROUND Although studies consistently show that beta-blockers reduce morbidity and mortality in patients with reduced ejection fraction (EF), data are inconsistent in patients with heart failure with mildly reduced ejection fraction (HFmrEF) and ...
S. Arnold, D. Silverman, Kensey Gosch, M. Nassif, M. Infeld, S. Litwin, M. Meyer, T. Fendler   +7 more
semanticscholar   +1 more source

Treatment for beta-blocker poisoning: a systematic review

Clinical toxicology, 2020
Introduction: Beta-adrenoreceptor antagonist (beta-blocker) poisoning is a common overdose which can lead to significant morbidity and mortality. Objective: To evaluate the effects of treatments for beta-adrenoreceptor antagonist poisoning.
J. Rotella, S. Greene, Z. Koutsogiannis, A. Graudins, Yit Hung Leang, K. Kuan, H. Baxter, Elyssia M. Bourke, A. Wong   +8 more
semanticscholar   +1 more source

Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction.

European Heart Journal - Cardiovascular Pharmacotherapy, 2020
AIMS This observational study aimed to investigate the association between beta-blocker therapy and clinical outcomes in patients with acute myocardial infarction (AMI), especially with mid-range or preserved left ventricular systolic function. METHODS
S. Joo, S. Kim, J. Choi, Hyeung-Keun Park, J. Beom, Jae-Geun Lee, S. Chae, Hyo‐Soo Kim, Young Jo Kim, M. Cho, C. Kim, S. Rha, Junghan Yoon, M. Jeong   +13 more
semanticscholar   +1 more source

Beta-blocker therapy and risk of vascular dementia: A population-based prospective study.

Vascular pharmacology, 2020
There are a few studies that report cognitive impairment as a complication of treatment with beta- blockers. We aimed to evaluate the longitudinal association between use of beta-blockers, as a class, and incident risk of all-cause dementia, vascular ...
H. Holm, F. Ricci, G. Martino, E. Bachus, E. Nilsson, P. Ballerini, O. Melander, O. Hansson, K. Nägga, K. Nägga, M. Magnusson, Artur Fedorowski   +11 more
semanticscholar   +1 more source

Beta-Blocker Interruption or Continuation after Myocardial Infarction.

New England Journal of Medicine
BACKGROUND The appropriate duration of treatment with beta-blocker drugs after a myocardial infarction is unknown. Data are needed on the safety and efficacy of the interruption of long-term beta-blocker treatment to reduce side effects and improve ...
J. Silvain, Guillaume Cayla, E. Ferrari, G. Rangé, E. Puymirat, N. Delarche, P. Guedeney, T. Cuisset, F. Ivanes, Thibault Lhermusier, Thibault Petroni, G. Lemesle, François Bresoles, J. Labèque, Thibaut Pommier, Jean-Guillaume Dillinger, F. Leclercq, Franck Boccara, Pascal Lim, Timothée Besseyre des Horts, T. Fourme, F. Jourda, Alain Furber, B. Lattuca, N. Redjimi, C. Thuaire, P. Deharo, N. Procopi, R. Dumaine, Michel S Slama, L. Payot, M. El Kasty, Karim Aacha, Abdourahmane Diallo, Eric Vicaut, Gilles Montalescot   +35 more
semanticscholar   +1 more source

Association between perioperative beta blocker use and cancer survival following surgical resection.

European Journal of Surgical Oncology, 2018
BACKGROUND Recent studies have demonstrated an association between beta-blocker exposure and improved survival in multiple cancer types. We sought to investigate the effects of beta-blockers at the time of index surgery for breast, lung, and colorectal ...
R. Musselman, S. Bennett, Wenbin Li, M. Mamdani, T. Gomes, C. van Walraven, R. Boushey, O. Al-Obeed, M. Al-Omran, R. Auer   +9 more
semanticscholar   +1 more source